Rockwood Wealth Management’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-107,329
| Closed | -$392K | – | 107 |
|
|
2025
Q1 | $392K | Hold |
107,329
| – | – | 0.04% | 62 |
|
|
2024
Q4 | $495K | Hold |
107,329
| – | – | 0.05% | 53 |
|
|
2024
Q3 | $999K | Hold |
107,329
| – | – | 0.11% | 37 |
|
|
2024
Q2 | $617K | Hold |
107,329
| – | – | 0.08% | 43 |
|
|
2024
Q1 | $720K | Sell |
107,329
-107,348
| -50% | -$720K | 0.09% | 38 |
|
|
2023
Q4 | $1.38M | Hold |
214,677
| – | – | 0.2% | 29 |
|
|
2023
Q3 | $1.07M | Hold |
214,677
| – | – | 0.18% | 27 |
|
|
2023
Q2 | $1.51M | Hold |
214,677
| – | – | 0.26% | 24 |
|
|
2023
Q1 | $1.33M | Sell |
214,677
-61,120
| -22% | -$379K | 0.26% | 23 |
|
|
2022
Q4 | $1.76M | Buy |
275,797
+151,767
| +122% | +$968K | 0.41% | 20 |
|
|
2022
Q3 | $1.06M | Buy |
+124,030
| New | +$1.06M | 0.34% | 22 |
|